FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Jen, Emily Y, Gao, Xin, Li, Liang, Zhuang, Luning, Simpson, Natalie E, Aryal, Baikuntha, Wang, Rong, Przepiorka, Donna, Shen, Yuan Li, Leong, Ruby, Liu, Chao, Sheth, Christopher M, Bowen, Steven, Goldberg, Kirsten B, Farrell, Ann T, Blumenthal, Gideon M, Pazdur, Richard
Published in Clinical cancer research (01.02.2020)
Published in Clinical cancer research (01.02.2020)
Get full text
Journal Article
FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease
Jen, Emily Y, Xu, Qing, Schetter, Aaron, Przepiorka, Donna, Shen, Yuan Li, Roscoe, Donna, Sridhara, Rajeshwari, Deisseroth, Albert, Philip, Reena, Farrell, Ann T, Pazdur, Richard
Published in Clinical cancer research (15.01.2019)
Published in Clinical cancer research (15.01.2019)
Get full text
Journal Article
FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia
Jen, Emily Y, Ko, Chia-Wen, Lee, Jee Eun, Del Valle, Pedro L, Aydanian, Antonina, Jewell, Charles, Norsworthy, Kelly J, Przepiorka, Donna, Nie, Lei, Liu, Jiang, Sheth, Christopher M, Shapiro, Marjorie, Farrell, Ann T, Pazdur, Richard
Published in Clinical cancer research (15.07.2018)
Published in Clinical cancer research (15.07.2018)
Get full text
Journal Article
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy
Jen, Emily Y, Wang, Xin, Li, Meng, Li, Hongshan, Lee, Shwu-Luan, Ni, Nina, Przepiorka, Donna, Vallejo, Jonathon, Leong, Ruby, Ma, Lian, Gehrke, Brenda J, McLamore, Sherita, Theoret, Marc R, de Claro, R Angelo
Published in Clinical cancer research (15.07.2022)
Published in Clinical cancer research (15.07.2022)
Get full text
Journal Article
Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective
Baines, Andrea C, Yazdy, Maryam Sarraf, Kasamon, Yvette L, Ershler, Rachel, Jen, Emily Y, Kanapuru, Bindu, Richardson, Nicholas C, Lane, Ashley, Carioti, Theresa, Theoret, Marc R, Pazdur, Richard, Gormley, Nicole J
Published in Clinical cancer research (01.08.2023)
Published in Clinical cancer research (01.08.2023)
Get full text
Journal Article
Considerations for Drug Development in Myelodysplastic Syndromes
Sekeres, Mikkael A, Kim, Nina, DeZern, Amy E, Norsworthy, Kelly J, Garcia, Jacqueline S, de Claro, R Angelo, Theoret, Marc R, Jen, Emily Y, Ehrlich, Lori A, Zeidan, Amer M, Komrokji, Rami S
Published in Clinical cancer research (14.07.2023)
Published in Clinical cancer research (14.07.2023)
Get full text
Journal Article
IL-2 regulates the expression of the tumor suppressor IL-24 in melanoma cells
Jen, Emily Y, Poindexter, Nancy J, Farnsworth, Elizabeth S, Grimm, Elizabeth A
Published in Melanoma research (01.02.2012)
Published in Melanoma research (01.02.2012)
Get more information
Journal Article
Minimal Residual Disease (MRD) Data in Hematologic Malignancy Drug Applications and Prescribing Information: FDA Analysis
Sarraf Yazdy, Maryam, Baines, Andrea C., Carioti, Theresa, Ershler, Rachel, Jen, Emily Y., Kanapuru, Bindu, Kasamon, Yvette L., Lane, Ashley, Richardson, Nicholas, Theoret, Marc, Gormley, Nicole J.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article